0001104659-24-024196.txt : 20240214
0001104659-24-024196.hdr.sgml : 20240214
20240214201939
ACCESSION NUMBER: 0001104659-24-024196
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240212
FILED AS OF DATE: 20240214
DATE AS OF CHANGE: 20240214
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kim Yong Man
CENTRAL INDEX KEY: 0001991122
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40427
FILM NUMBER: 24641631
MAIL ADDRESS:
STREET 1: NKGEN BIOTECH, INC.
STREET 2: 3001 DAIMLER STREET
CITY: SANTA ANA
STATE: CA
ZIP: 92705
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NKGen Biotech, Inc.
CENTRAL INDEX KEY: 0001845459
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3001 DAIMLER ST,
CITY: SANTA ANA
STATE: CA
ZIP: 92705
BUSINESS PHONE: (949) 396-6830
MAIL ADDRESS:
STREET 1: 3001 DAIMLER ST,
CITY: SANTA ANA
STATE: CA
ZIP: 92705
FORMER COMPANY:
FORMER CONFORMED NAME: Graf Acquisition Corp. IV
DATE OF NAME CHANGE: 20210210
4
1
tm246293-4_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2024-02-12
0
0001845459
NKGen Biotech, Inc.
NKGN
0001991122
Kim Yong Man
NKGEN BIOTECH, INC.
3001 DAIMLER STREET
SANTA ANA
CA
92705
0
1
0
0
CSO and CIO
0
Stock Option (right to buy)
1.62
2024-02-12
4
A
0
75000
0.00
A
Common Stock
75000
75000
D
On February 12, 2024, the reporting person was granted 75,000 options pursuant to the Company's 2023 Equity Incentive Plan, vesting in equal installments on the first of each month, beginning October 1, 2023, and ending October 1, 2027, subject to the Reporting Person's continued service with the Issuer on each respective vesting date.
/s/ Yong Man Kim
2024-02-14